RCE in Zkteco Zkbio Access Ivs
CVE-2024-1706
A vulnerability was determined in ZKTeco ZKBio Access IVS up to 3.3.2. This impacts an unknown function of the component Department Name Search Bar. This manipulation with the input <marquee>hi causes cross site scripting. Remote exploitation of the attack is possible. The exploit has been publicly disclosed and may be utilized. The vendor explains: "ZKBio Access IVS is no longer maintained and the product has been replaced by ZKBio CVAccess, it is recommended to replace it with the latest version of ZKBio CVAccess." This vulnerability only affects products that are no longer supported by the maintainer.
Vulnerability class: XSS (Cross-Site Scripting)
EPSS: 0.004 (35.5th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 3.5 (Low). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N.
Affected products
- Zkteco Zkbio Access Ivs — versions 3.3.0, 3.3.1, 3.3.2
- Zkteco Zkbio_access_ivs
Weakness classification (CWE)
References
- cna@vuldb.com (technical-description, Third Party Advisory, vdb-entry)
- cna@vuldb.com (signature, Permissions Required, permissions-required)
- cna@vuldb.com (third-party-advisory)
- cna@vuldb.com (third-party-advisory)
- cna@vuldb.com (Third Party Advisory, exploit)
- cna@vuldb.com (related)
Frequently asked questions
- What is CVE-2024-1706?
- CVE-2024-1706 is a low-severity vulnerability in Zkteco Zkbio Access Ivs, classified under Cross-site Scripting. CVSS score: 3.5/10. Published 2024-02-21.
- How severe is CVE-2024-1706?
- Low severity. CVSS v3 base score is 3.5 out of 10.